Liquidia Corp (LQDA) Financial Statements (2026 and earlier)

Company Profile

Business Address 419 DAVIS DRIVE, SUITE 100
MORRISVILLE, NC 27560
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments190,680157,496173,422169,758176,479204,368
Cash and cash equivalent190,680157,496173,422169,758176,479204,368
Receivables54,09335,9599,9681,2472,7194,202
Inventory, net of allowances, customer advances and progress billings23,80224,5346,4441,34924138
Inventory23,80224,5346,4441,34924138
Other undisclosed current assets4,8268,7305,7494,8515,6665,604
Total current assets:273,401226,719195,583177,205185,105214,212
Noncurrent Assets
Operating lease, right-of-use asset3,9494,0144,0754,1324,1871,371
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization11,84410,7049,5408,4848,2987,784
Intangible asset, including goodwill, after accumulated amortization6,8556,8916,9557,0117,0597,122
Goodwill3,9033,9033,9033,9033,9033,903
Intangible asset, excluding goodwill, after accumulated amortization2,9522,9883,0523,1083,1563,219
Restricted cash and investments3,5043,5043,504   
Deferred income tax assets      
Other noncurrent assets13,1718,95422,42015,54210,9187,758
Other undisclosed noncurrent assets15,21015,19515,33315,05514,74614,639
Total noncurrent assets:54,53349,26261,82750,22445,20838,674
TOTAL ASSETS:327,934275,981257,410227,429230,313252,886
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities32,39822,23127,11420,10619,21215,040
Accounts payable3,6786,01911,3468,6754,6892,298
Accrued liabilities28,72016,21215,76811,43114,52312,742
Other undisclosed current liabilities103,37080,71151,29640,41222,56918,798
Total current liabilities:135,768102,94278,41060,51841,78133,838
Noncurrent Liabilities
Liabilities, other than long-term debt8,3848,2847,9707,5357,3007,196
Deferred income tax liabilities      
Estimated litigation liability8,3848,2847,9707,5357,3007,196
Other undisclosed noncurrent liabilities139,034142,703155,841109,663103,957101,334
Total noncurrent liabilities:147,418150,987163,811117,198111,257108,530
Total liabilities:283,186253,929242,221177,716153,038142,368
Equity
Equity, attributable to parent44,74822,05215,18949,71377,275110,518
Common stock878786858585
Additional paid in capital670,974662,833652,438645,384636,682631,556
Accumulated deficit(626,313)(640,868)(637,335)(595,756)(559,492)(521,123)
Total equity:44,74822,05215,18949,71377,275110,518
TOTAL LIABILITIES AND EQUITY:327,934275,981257,410227,429230,313252,886

Income Statement (P&L) ($ in thousands)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Revenues92,02154,3428,8373,1202,9174,448
Cost of revenue(6,844)(2,873)(1,297)(1,517)(1,354)(1,565)
Cost of product and service sold    (1,517)(1,354)(1,565)
Gross profit:85,17751,4697,5401,6031,5632,883
Operating expenses(65,390)(49,702)(45,045)(37,028)(37,670)(32,072)
Operating income (loss):19,7871,767(37,505)(35,425)(36,107)(29,189)
Nonoperating income (expense)(5,232)(5,300)(4,074)(2,942)(2,262)6,034
Investment income, nonoperating1,6671,6451,5841,7282,1041,815
Interest and debt expense(6,899)(6,945)(5,658)(4,670) 7,215
Income (loss) from continuing operations before equity method investments, income taxes:7,656(10,478)(47,237)(43,037)(38,369)(15,940)
Other undisclosed income from continuing operations before income taxes      
Income (loss) from continuing operations before income taxes:7,656(10,478)(47,237)(43,037)(38,369)(15,940)
Income tax expense      
Income (loss) from continuing operations:7,656(10,478)(47,237)(43,037)(38,369)(15,940)
Other undisclosed net income 6,899  4,670  
Net income (loss):14,555(10,478)(47,237)(38,367)(38,369)(15,940)
Other undisclosed net income (loss) attributable to parent  6,9455,658  (7,215)
Net income (loss) available to common stockholders, diluted:14,555(3,533)(41,579)(38,367)(38,369)(23,155)

Comprehensive Income ($ in thousands)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Net income (loss):14,555(10,478)(47,237)(38,367)(38,369)(15,940)
Comprehensive income (loss), net of tax, attributable to parent:14,555(10,478)(47,237)(38,367)(38,369)(15,940)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: